Intercept Pharmaceuticals, Inc. Return on Tangible Equity 2013-2023 | ICPT

Current and historical return on tangible equity values for Intercept Pharmaceuticals, Inc. (ICPT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-09-30 $-0.06B $0.07B -82.67%
2023-06-30 $0.21B $0.07B 247.62%
2023-03-31 $0.21B $0.07B -807.84%
2022-12-31 $0.22B $0.09B -163.40%
2022-09-30 $0.21B $0.11B -100.73%
2022-06-30 $-0.07B $-0.37B 24.03%
2022-03-31 $-0.07B $-0.37B 29.73%
2021-12-31 $-0.09B $-0.18B 48.99%
2021-09-30 $-0.11B $-0.16B 58.95%
2021-06-30 $-0.17B $-0.20B 96.57%
2021-03-31 $-0.22B $-0.20B 153.47%
2020-12-31 $-0.27B $-0.17B 266.67%
2020-09-30 $-0.32B $-0.13B 666.67%
2020-06-30 $-0.34B $-0.08B -1965.22%
2020-03-31 $-0.35B $-0.04B -429.72%
2019-12-31 $-0.34B $0.05B -454.13%
2019-09-30 $-0.33B $0.13B -494.81%
2019-06-30 $-0.31B $0.18B -532.77%
2019-03-31 $-0.32B $-0.06B -612.56%
2018-12-31 $-0.31B $0.02B -588.57%
2018-09-30 $-0.33B $0.10B -641.55%
2018-06-30 $-0.34B $0.15B -611.66%
2018-03-31 $-0.35B $-0.05B -573.98%
2017-12-31 $-0.36B $0.02B -268.40%
2017-09-30 $-0.37B $0.11B -176.82%
2017-06-30 $-0.39B $0.17B -135.44%
2017-03-31 $-0.38B $0.24B -108.44%
2016-12-31 $-0.41B $0.32B -101.04%
2016-09-30 $-0.38B $0.42B -79.29%
2016-06-30 $-0.34B $0.42B -62.79%
2016-03-31 $-0.31B $0.49B -50.42%
2015-12-31 $-0.23B $0.60B -37.68%
2015-09-30 $-0.17B $0.68B -34.12%
2015-06-30 $-0.16B $0.72B -39.23%
2015-03-31 $-0.08B $0.40B -26.15%
2014-12-31 $-0.28B $0.23B -180.89%
2014-09-30 $-0.26B $0.26B -217.95%
2014-06-30 $-0.26B $0.29B -332.69%
2014-03-31 $-0.30B $-0.15B -897.78%
2013-12-31 $-0.07B $0.08B -76.57%
2013-09-30 $-0.09B $0.09B -102.99%
2013-06-30 $-0.06B $0.12B -98.77%
2013-03-31 $-0.05B $0.06B -166.93%
2012-12-31 $-0.05B $0.07B -278.79%